HORIZON-HLTH-2024-DISEASE-03-two-stage

Tackling diseases (Two stage - 2024)

Topic(s) Title Budget disponible (€) Action(s) Ouverture Clôture Clôture (2nde étape)
HORIZON-HLTH-2024-DISEASE-03-08-two-stage Comparative effectiveness research for healthcare interventions in areas of high public health need 45 000 000 HORIZON Research and Innovation Actions 26/04/2023
19/09/2023
11/04/2024
Fermé
HORIZON-HLTH-2024-DISEASE-03-11-two-stage Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness 30 000 000 HORIZON Research and Innovation Actions 26/04/2023
19/09/2023
11/04/2024
Fermé
HORIZON-HLTH-2024-DISEASE-03-13-two-stage Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders 25 000 000 HORIZON Research and Innovation Actions 26/04/2023
19/09/2023
11/04/2024
Fermé
HORIZON-HLTH-2024-DISEASE-03-14-two-stage Tackling high-burden for patients, under-researched medical conditions 25 000 000 HORIZON Research and Innovation Actions 26/04/2023
19/09/2023
11/04/2024
Fermé
Topic(s)
Fermé
HORIZON-HLTH-2024-DISEASE-03-08-two-stage
Comparative effectiveness research for healthcare interventions in areas of high public health need
Clôture : 19/09/2023
Clôture (2nde étape) : 11/04/2024
Fermé
HORIZON-HLTH-2024-DISEASE-03-11-two-stage
Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness
Clôture : 19/09/2023
Clôture (2nde étape) : 11/04/2024
Fermé
HORIZON-HLTH-2024-DISEASE-03-13-two-stage
Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
Clôture : 19/09/2023
Clôture (2nde étape) : 11/04/2024
Fermé
HORIZON-HLTH-2024-DISEASE-03-14-two-stage
Tackling high-burden for patients, under-researched medical conditions
Clôture : 19/09/2023
Clôture (2nde étape) : 11/04/2024